Low-dose oral use of interferon inhibits virally induced myocarditis

Journal of Interferon and Cytokine Research

Volumn 19, Issue 8, 1999, Pages 863-867

  Lawson, Cassandra M ^a,b   Beilharz, Manfred W ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; IMMUNOMODULATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MOUTH MUCOSA; MYOCARDITIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MYOCARDITIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON TYPE I; MICE; MICE, INBRED BALB C; MYOCARDITIS;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MURINAE;

EID: 0032840243     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313370     Document Type: Article

References (26)

1. KISHIMOTO, C., and HIRAOKA, Y. (1994). Clinical and experimental studies in myocarditis. Curr. Opin. Cardiol. 9, 349-356.
2. SEE, D.M., and TILLES, J.G. (1991). Viral myocarditis. Rev. Infect. Dis. 13, 951-956.
3. SOLE, M.J., and LIU, P. (1993). Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. 22(Suppl. A), 99A-105A.
4. MOLKENTIN, J.D., LU, J.-R., ANTOS, C.L., MARKHAM, B., RICHARDSON, J., ROBBINS, J., GRANT, S.R., and OLSON, E.N. (1998). A calcinerin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228.
5. WREGHITT, T.G., HAKIM, M., GRAY, J.J., and KUCIA, S. (1988). Cytomegalovirus infections in heart and lung transplant recipients. J. Clin. Pathol. 41, 660-667.
6. FERNANDO, S., BOOTH, J., BORISKIN, Y., BUTCHER, P., CARRINGTON. D., STEEL, H., TYRHORN, Y., CORBISHLEY, C., KEELING, P., MURDAY, A., et al. (I994). Association of cytomegalovirus infection with post-transplantation cardiac rejection as studied using polymerase chain reaction. J. Med. Virol. 42, 396-404.
7. HERSKOWITZ, A., WU. T.C, WILLOUGHBY, S.B., VLAHAR, D., ANASARI, A.A., BEESCHORNER, W.E., and BAUGHMAN, K.L. (1994), Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late stage infection with human immunodeficiency vims. J. Am. Coll. Cardiol. 24, 1025-1032.
8. ARBUSTINI, E., GRASSO, M., DIEGOLI, M., PERCIVALLE, E., GROSSI, P., BRAMERIO, M., CAMPANA, C., GOGGI, C., GAVAZZI, A., and VIGANO, M. (1992). Histopathologic profile of human cytomegalovirus infections in patients with heart transplants. Am. J. Clin. Pathol. 98, 205-213.
9. MAISCH, B., SCHONIAN, U., CROMBACH, M., WENDL, I., BETHGE, C, HERZUM, M., and KLEIN, H.H. (1993). Cytomegalovirus associated inflammatory heart muscle disease. Scand, J. Infect. Dis. Suppl. 88, 135-148.
10. ANDO, H., SHIRAMIZU, T., and HISANAOU, R. (1992), Dilated cardiomyopathy caused by cytomegalovirus infection in a renal transplant recipient. Jap. Heart. J. 33, 409-412.
11. BARTHOLOMAEUS, W.N., O'DONOGUE, H., FOTI, D., LAWSON, C.M., SHELLAM, G.R., and REED, W.D. (1988). Multiple autoantibodies following cytomegalo virus infection: Virus distribution and specificity of autoantibodies. Immunology 64, 397-405.
12. LAWSON, C.M., O'DONOGUE, H., BARTHOLMAEUS, W.N., and REED, W.D. (1990). Genetic control of cytomegalovirus induced myocarditis. J. Gen. Virol. 69, 20-26.
13. LAWSON, C.M., O'DONOGUE, H., and REED, W.D. (1989). The role of T cells in mouse cytomegalovirus myocarditis. Immunology 67, 132-134.
14. O'DONOGHUE, H., LAWSON, CM., and REED, W.D. (1990). Autoantibodies to cardiac myosin in mouse cytomegalovirus induced myocarditis. Immunology 71, 20-28.
15. FAIRWEATHER, D., LAWSON, C.M., CHAPMAN, A.J., BROWN, C.M.S., BOOTH, T.W.M., PAPADIMITRIOU, J.M., and SHELLAM, G.R. (1998). Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology 94, 263-270.
16. LAWSON, C.M., O'DONOGHUE, H., FARRELL, H.E., SHELLAM, G.R., and REED, W.D. (1991). Munne anti-cytomegalovirus monoclonal antibodies with autoreactivity. Immunology 72, 427-433.
17. MAISCH, B., DEEG, P., LIEBAU, G., and KOCHSIEK, K. (1983). Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am. J. Cardiol. 52, 1072-1078.
18. NEU, N., PLOIER, B., and OFNER, C. (1990). Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J. Immunol. 145, 4094-4100.
19. LAWSON, CM., O'DONOGUE, H.L., and REED, W.D. (1992). Mouse cytomegalovirus infection induces antibodies which crossreact with virus and cardiac myosin. A model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology 75, 513-519.
20. BEILHARZ, M.W., McDONALD, W., WATSON, M.W., HENG, J., McGEACHIE, J., and LAWSON, C.M. (1997). Low dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J. Interferon & Cytokine Res. 17, 625-630.
21. BOSIO, E., BEILHARZ, M.W., WATSON, M.W., and LAWSON, C.M. (1998). Efficacy of low-dose oral use of type I interferon in cytomegalovirus infection in vivo. J. Cytokine Interferon Res., 19, 869-876.
22. LAWSON, C.M., GRUNDY, J.E., and SHELLAM, G.R. (1988). Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J. Gen. Virol. 69, 1987-1998.
23. REDDEHASE, M.J., MUTTER, W., MUNCH, K., BUHRING, H.-J., and KOSINOWSKI, U.H. (1987). CDS-positive T lym- phocytes specific for murine cytomegalov irus immediateearly antigens mediate protective immunity. J. Virol. 61, 3102-3108.
24. JONJIC, S., MUTTER, W., WEILAND, G., REDDEHASE, M.J., and KOSINOWSKI. U.H. (1989). Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4-positive T lymphocytes. J. Exp. Med. 169, 1199-1212.
25. LAWSON, C.M., YEOW, W.-S., LEE, C.M., and BEILHARZ, M.W. (1997). In vivo expression of an Interferon -α gene by intramuscular injection of naked DNA. J. Interferon α Cytokine Res. 17, 255-261.
26. YEOW, W.-S., LAWSON, C.M., and BEILHARZ, M.W. (1998). Antiviral activities of interferon-α subtypes in vivo. J. Immunol. 160, 2932-2939.